Abdul Mannan: A Normal Factor Level Can Still Miss the Story
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, shared a post on LinkedIn:
“A normal factor level can still miss the story.
That is the false reassurance trap in haemophilia carriers.
The lab result matters. Of course it does. But it should never be used as a permission slip to ignore bleeding symptoms.
Here’s what I want every trainee to remember:
- FVIII and FIX levels are risk clues
- Bleeding history is a clinical signal
- Heavy periods, nosebleeds, oral bleeding, bruising, procedure bleeding, and joint pain all matter
- A structured BAT or HMB screen can change the conversation
- Symptomatic carriers need a documented plan and review
- Haemophilia Carrier Post 1 of 8
One number rarely explains the whole patient.
The better question is not, ‘Is the factor level normal?’
The better question is, ‘Does the bleeding phenotype fit the life this patient is living?’
That small change can stop years of reassurance without action.
What phrase do you use in clinic to move from ‘normal result’ to ‘proper bleeding assessment’?”
More posts from Dr Abdul Mannan on Hemostasis Today.
-
Aug 31, 2026, 14:07Ben Dowsing: Can Heart Failure Therapy Be Safely Withdrawn After HER2 Cardiotoxicity Recovery
-
Aug 31, 2026, 14:06Khalid Alfawaz: Signed Consent Doesn’t Always Mean Informed
-
Aug 31, 2026, 14:03Adil Aftab: Anticoagulation in CKD – Key Updates from the 2026 ESC Guidelines
-
Aug 31, 2026, 14:01Isa Oboirien: Why Might Factor XI Inhibition Work Differently in Stroke and ACS?
-
Aug 31, 2026, 13:55Mike Morrissey: Advancing Europe’s Cardiovascular Health Agenda at ESC Congress 2026
-
Aug 31, 2026, 13:44Penilla Gunther: Patient Voices Take Center Stage in Cardiovascular Prevention at ESC Congress 2026
-
Aug 31, 2026, 13:42Mohamed Saleh Gomaa: Master the Latest in PE Management
-
Aug 31, 2026, 13:38Lyn Kleinbach-Reilly: A New Standard for Coagulation Testing in Neonatal Care
-
Aug 31, 2026, 13:36Rafael Gomes: Can Prasugrel Replace Ticagrelor in ACS Treatment?